Lim, R., Bereznicki, L., Corlis, M., Kalisch Ellett, L. M., Kang, A. C., Merlin, T., . . . Roughead, E. E. (2020). Reducing medicine-induced deterioration and adverse reactions (ReMInDAR) trial: Study protocol for a randomised controlled trial in residential aged-care facilities assessing frailty as the primary outcome. BMJ Open.
Stile di citazione ChicagoLim, Renly, et al. "Reducing Medicine-induced Deterioration and Adverse Reactions (ReMInDAR) Trial: Study Protocol for a Randomised Controlled Trial in Residential Aged-care Facilities Assessing Frailty As the Primary Outcome." BMJ Open 2020.
Citazione MLALim, Renly, et al. "Reducing Medicine-induced Deterioration and Adverse Reactions (ReMInDAR) Trial: Study Protocol for a Randomised Controlled Trial in Residential Aged-care Facilities Assessing Frailty As the Primary Outcome." BMJ Open 2020.